Alcohol and Alcoholism Advance Access originally published online on January 22, 2008
Alcohol and Alcoholism 2008 43(2):148-150; doi:10.1093/alcalc/agm169
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invited Commentary
Serotonin transporter (SERT) brain density and neurobiological cloninger subtypes model: a lesson by human autoradiography studies
1 Institute of Internal Medicine, Catholic University of Rome, Rome, Italy
2 Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University Medical School, Providence, RI, USA
* Author to whom correspondence should be adressed at: Institute of Internal Medicine, Catholic University of Rome, Largo A. Gemelli, 8 I-00168 Rome, Italy. Tel.: +39–06-30154334; Fax: +39–06-35502775; E-mail: g.addolorato{at}rm.unicatt.it
 |
Abstract |
|---|
Cloninger proposed a neurochemical model of alcoholism suggesting that type 2 alcoholics have serotonergic deficits with intact dopaminergic system, whereas the type 1 alcoholics have defected dopaminergic system. The work by Storvik and colleagues recently published on Alcohol and Alcoholism shows some interesting differences on the SERT brain density between the type I and type II alcoholic subtypes. Critically, these findings on different serotonergic role in subtypes of alcohol-dependence revive the concept that alcohol addiction is a heterogeneous disorder associated with varying neurochemical abnormalities. Studies testing serotonergic medications in alcohol-dependent patients classified according to subtypes have shown interesting findings. Accordingly, the identification and standardization of alcoholic subtypes could be useful in guiding research on treatment. New developments in the neurobiological understanding of subtypes of alcoholic patients, could led to get the basis for a more personalized pharmacological therapy.